Myopic Choroidal Neovascularization
📧 Sign up to get email alerts when something new happens for Myopic Choroidal Neovascularization.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-10-03FDA Approved: BYOOVIZ — Supplemental Application (BIOGEN INC.)
FDA approved Biogen's BYOOVIZ (ranibizumab-nuna) via a supplemental application, providing an additional approval for this ranibizumab biosi…
-
FDA approval · 2023-06-16FDA Approved: BYOOVIZ — Supplemental Application (BIOGEN INC.)
FDA approved a supplemental application for BYOOVIZ (ranibizumab-nuna) from Biogen Inc.
-
FDA approval · 2022-08-15FDA Approved: BYOOVIZ — Supplemental Application (BIOGEN INC.)
FDA approves Biogen's BYOOVIZ (ranibizumab-nuna) via a supplemental application, authorizing the biosimilar for the same ocular indications …
-
FDA approval · 2022-06-09FDA Approved: BYOOVIZ — Supplemental Application (BIOGEN INC.)
The FDA approved a supplemental application for BYOOVIZ (ranibizumab-nuna) from Biogen, authorizing its use as a biosimilar to ranibizumab.